Valued at $20 billion, the deal is one of the largest in the sector and has reignited concerns about a possible AI investment ...
Morning Overview on MSN
New method could mass-produce cancer-fighting natural killer cells
Cancer immunotherapy has been transformed by engineered T cells, but those bespoke treatments are slow, expensive, and out of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback